Evidence map›Paper›PMID 10212321›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1999

Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors.

E Galarraga, S Hernández-López, A Reyes, I Miranda, F Bermudez-Rattoni, C Vilchis, J Bargas

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Review
  2. Article
  3. Activation of MBritish journal of pharmacology · 2024
    Article
  4. Advances in the study of cholinergic circuits in the central nervous system.Annals of clinical and translational neurology · 2023
    Review
  5. Modulation of neuronal excitability by binge alcohol drinking.Frontiers in molecular neuroscience · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Cholinergic modulation of striatal microcircuits.The European journal of neuroscience · 2019
    Review
  12. Article
  13. The striatal cholinergic system in L-dopa-induced dyskinesias.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
  14. Article
  15. Review
  16. MNeuropharmacology · 2017
    Article
  17. Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E GalarragaDepartment of Biophysics, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México City DF 04510, Mexico.
S Hernández-López
A Reyes
I Miranda
F Bermudez-Rattoni
C Vilchis
J Bargas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is demonstrated that acetylcholine released from cholinergic interneurons modulates the excitability of neostriatal projection neurons. Physostigmine and neostigmine increase input resistance (RN) and enhance evoked discharge of spiny projection neurons in a manner similar to muscarine. Muscarinic RN increase occurs in the whole subthreshold voltage range (-100 to -45 mV), remains in the presence of TTX and Cd2+, and can be blocked by the relatively selective M1,4 muscarinic receptor antagonist pirenzepine but not by M2 or M3 selective antagonists. Cs+ occludes muscarinic effects at potentials more negative than -80 mV. A Na+ reduction in the bath occludes muscarinic effects at potentials more positive than -70 mV. Thus, muscarinic effects involve different ionic conductances: inward rectifying and cationic. The relatively selective M2 receptor antagonist AF-DX 116 does not block muscarinic effects on the projection neuron but, surprisingly, has the ability to mimic agonistic actions increasing RN and firing. Both effects are blocked by pirenzepine. HPLC measurements of acetylcholine demonstrate that AF-DX 116 but not pirenzepine greatly increases endogenous acetylcholine release in brain slices. Therefore, the effects of the M2 antagonist on the projection neurons were attributable to autoreceptor block on cholinergic interneurons. These experiments show distinct opposite functions of muscarinic M1- and M2-type receptors in neostriatal output, i.e., the firing of projection neurons. The results suggest that the use of more selective antimuscarinics may be more profitable for the treatment of motor deficits.

Indexed as

AcetylcholineAnimalsCadmium ChlorideCesiumChloridesElectric StimulationIn Vitro TechniquesMembrane PotentialsMuscarineMuscarinic AgonistsMuscarinic AntagonistsNeostriatumNeuronsPhysostigminePirenzepineRatsAcetylcholineCadmium ChlorideCesiumcesium chlorideChloridesMuscarineMuscarinic AgonistsMuscarinic AntagonistsotenzepadPhysostigminePirenzepineReceptor, Muscarinic M1Receptor, Muscarinic M2Receptor, Muscarinic M3Receptor, Muscarinic M4Receptors, MuscarinicTetrodotoxin

Identifiers

PMID10212321
PMCPMC6782250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.